GENELUX Corp — Director's Dealing 2025

Sep 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENELUX Corp (GNLX)
CIK: 0001231457
Period of Report: 2025-09-01

Reporting Person: Zindrick Thomas (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-01	Stock Option (Right to Buy)	$6.00	D	925000	Disposed	2027-09-18	Common stock (925000)	Direct
2025-09-01	Stock Option (Right to Buy)	$3.33	A	925000	Acquired	2027-09-18	Common stock (925000)	Direct
2025-09-01	Stock Option (Right to Buy)	$6.00	D	157372	Disposed	2030-03-22	Common stock (157372)	Direct
2025-09-01	Stock Option (Right to Buy)	$3.33	A	157372	Acquired	2030-03-22	Common stock (157372)	Direct
2025-09-01	Stock Option (Right to Buy)	$6.00	D	23568	Disposed	2030-09-23	Common stock (23568)	Direct
2025-09-01	Stock Option (Right to Buy)	$3.33	A	23568	Acquired	2030-09-23	Common stock (23568)	Direct
2025-09-01	Stock Option (Right to Buy)	$22.40	D	250000	Disposed	2033-09-10	Common stock (250000)	Direct
2025-09-01	Stock Option (Right to Buy)	$3.33	A	250000	Acquired	2033-09-10	Common stock (250000)	Direct

Footnotes

F1: The shares subject to these options are fully vested.

F2: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options.

F3: The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.